Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 04, 2023 16:30 ET | Source: Aceragen, Inc.

Aceragen, Inc. to Delist from The Nasdaq Stock Market

DURHAM, N.C. and EXTON, Pa., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (the “Company”) (Nasdaq: ACGN), announced today that the Company intends to voluntarily terminate the listing of its...
May 30, 2023 16:25 ET | Source: Aceragen, Inc.

Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing

DURHAM, N.C. and EXTON, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (the “Company”) (Nasdaq: ACGN), announced today that on May 24, 2023, the Company received a notice from The Nasdaq Stock...
February 06, 2023 09:25 ET | Source: Aceragen, Inc.

Aceragen Announces Recommendation of Data Monitoring Committee in Terra Study

DURHAM, N.C. and EXTON, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (Nasdaq: ACGN) a clinical-stage biopharmaceutical company committed to transforming the care of people living...